Malignant Large Intestinal Neoplasm — Trials

Malignant Large Intestinal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,500 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,622
Recruiting: 914
Ph III recruiting: 106
Growth YoY: +15.1%
Industry share: 22%
Top sponsor: Fudan University
Termination share: 25.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (742)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07614048	Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS	available	—	—	Providence Health & ServicesOTHER	0	Jul 23, 2026	clinicaltrials
NCT04566393	Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies	available	—	—	xCuresINDUSTRY	1	Jun 4, 2026	clinicaltrials